Grünenthal Pharma receives the Andalusian SEMG award in the category of pharmaceutical industry.
-this award recognizes the efforts of Grünenthal Pharma in the field of biomedical research aimed at alleviating the pain.
Madrid, June of 2011- the effort of Grünenthal Pharma in the field of biomedical research aimed at alleviating the pain has been recognized in the 4th edition of the Andalusians Awards general physicians and family, that Andalusia SEMG acknowledges the work and the work of various public and private institutionspeople, companies and societies in the field of health.
for Grünenthal Pharma, general practitioners and family are the first direct, close and daily contact with the patient, so it is the responsibility of this company and its commitment to, offer all the support and the necessary tools for the optimal development of their activity care.
in this sense, notably labour Grünenthal Pharma takes place in the development of new therapeutic entities to improve the quality of life of patient with pain, as well as in the area of training to health professionals, focused on improving the knowledge about this serious health problem, its diagnosisboarding and treatment.
about Grünenthal.
Grünenthal is a pharmaceutical company reference at global level in the treatment of pain for patients, doctors and health managers. Innovation is one of its fundamental principles and one of the keys to be leaders in the global market for moderate to severe pain. Grünenthal is an independent German company family-owned, with offices in 35 countries around the world. Founded in 1946, Grünenthal has 512 employees in the region of Iberia and approximately 4,900 at the global level. In 2009 the global sales figures reached the 881 million euros. Also, Grünenthal Pharma ranked 17 in the Group of companies of between 250 and 500 employees in the prestigious ranking ‘ Best WorkPlaces 2011 Spain ’, produced by Great Place to Work ®.
